• 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Vaccination

CTech 24/7

  • CyberArk, not SentinelOne, was always the goal, says Palo Alto CEO
  • Palo Alto CEO on $25B CyberArk deal: “This is the lowest our stock will be for the next five years”
  • CyberArk’s $25B exit enriches global funds, not Israelis
  • Check Point not for sale, says CEO as Palo Alto buys CyberArk for $25B
More stories in CTech

Vaccination

3 stories about Vaccination
  • Ran Balicer, Director of Health Policy Planning at Clalit. Photo: Orel Cohen

    Israeli data confirms real-world efficiency rate of Covid-19 vaccine

    25.02.21|Ynet and ReutersThe results of the study for the Clalit Research Institute were close to those in clinical trials last year which found two doses were found to be 95% effective

  • Thousands of ultra-Orthodox Jews take part in a funeral in Jerusalem. Photo: Yossi Weizel

    Israel extends lockdown despite succesfull vaccination drive

    01.02.21|ReutersBan on international flights to remain in place until Sunday; ministers vote to double fines for violators amid political standoff

  • Vaccines (illustration). Photo: Bloomberg

    Anti-Vaxxers and Autism: Disability Culture vs. Ignorance

    29.11.19|Dov GreenbaumAnti-vaxxers have existed under the radar for a long time, but in recent years unheard-of outbreaks of nearly eradicated diseases, like measles or polio, brought the situation to a head

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive